Chad
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 4.87 (0.48 - 36.43) | 2015 | Modelled | WHO |
| 10.5 (8.20 - 12.30) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 12.39 (9.89 - 14.46) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 13.9 (11.06 - 16.30) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.3 (11.09 - 17.33) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.29 (10.95 - 16.95) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.29 (10.63 - 17.04) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.49 (10.85 - 17.20) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.87 (11.29 - 17.62) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.31 (11.77 - 18.10) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.71 (12.18 - 18.59) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.94 (12.38 - 19.04) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.1 (12.63 - 19.01) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.3 (12.88 - 19.15) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.5 (13.12 - 19.41) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.67 (13.35 - 19.63) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.76 (13.42 - 19.93) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.82 (13.46 - 19.85) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.9 (13.47 - 19.82) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.99 (13.50 - 19.97) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.08 (13.51 - 20.20) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.15 (13.53 - 20.52) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.26 (13.61 - 20.53) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.42 (13.65 - 20.55) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.6 (13.62 - 20.76) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.75 (13.60 - 21.04) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.8 (13.47 - 21.22) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.77 (13.62 - 20.97) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.71 (13.72 - 20.72) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.59 (13.71 - 20.66) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.44 (13.79 - 20.54) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.23 (13.72 - 20.47) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.06 (10.51 - 15.25) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.08 (0.29 - 26.20) | 2015 | Modelled | WHO |
| 7.88 (5.66 - 10.01) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 8.6 (6.20 - 10.87) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.32 (6.59 - 11.67) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.66 (6.58 - 12.67) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.6 (6.43 - 12.26) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.53 (6.02 - 12.14) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.64 (6.17 - 12.17) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.85 (6.36 - 12.44) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.15 (6.71 - 12.91) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.52 (7.10 - 13.52) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.93 (7.53 - 14.30) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.65 (8.15 - 14.98) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.74 (8.93 - 16.08) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.92 (9.86 - 17.46) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.9 (10.64 - 18.83) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.41 (10.94 - 19.66) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.56 (11.19 - 19.47) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.65 (11.39 - 19.62) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.7 (11.48 - 19.50) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.74 (11.36 - 19.45) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.78 (11.41 - 19.59) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.88 (11.46 - 19.74) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.05 (11.29 - 20.04) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.24 (11.14 - 20.40) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.39 (10.92 - 20.61) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.45 (10.77 - 20.91) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.41 (10.83 - 20.91) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.32 (10.85 - 20.65) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.18 (10.81 - 20.55) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.98 (10.85 - 20.59) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.73 (10.91 - 20.56) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.79 (9.15 - 12.78) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,516,000 (1,189,000 - 1,771,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 2,032,220 (1,622,540 - 2,371,530) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 2,079,690 (1,671,480 - 2,427,250) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,136,010 (1,695,110 - 2,505,370) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,120,540 (1,643,390 - 2,560,650) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,043,530 (1,564,100 - 2,422,620) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,970,050 (1,465,960 - 2,346,790) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,926,950 (1,436,390 - 2,289,120) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,907,470 (1,445,750 - 2,254,690) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,895,170 (1,455,100 - 2,241,560) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,875,760 (1,454,100 - 2,220,470) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,836,880 (1,422,840 - 2,190,770) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,789,000 (1,400,830 - 2,112,960) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,746,760 (1,380,340 - 2,053,310) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,705,810 (1,355,960 - 2,007,280) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,662,380 (1,330,740 - 1,958,840) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,612,940 (1,292,760 - 1,918,360) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,562,300 (1,250,780 - 1,843,940) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,516,400 (1,205,310 - 1,779,550) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,473,480 (1,166,540 - 1,730,060) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,432,020 (1,128,960 - 1,695,440) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,390,830 (1,094,300 - 1,666,470) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,354,080 (1,069,900 - 1,610,900) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,323,680 (1,033,720 - 1,560,770) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,295,290 (1,000,050 - 1,527,420) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,265,000 (965,740 - 1,501,050) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,229,420 (929,246 - 1,467,690) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,189,720 (909,787 - 1,406,440) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,149,050 (891,186 - 1,348,050) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,107,450 (864,522 - 1,300,010) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,064,950 (839,817 - 1,254,220) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,021,440 (813,952 - 1,213,870) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 10.9 (7.94 - 14.60) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 15.91 (10.74 - 22.54) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.54 (10.58 - 22.14) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.66 (10.53 - 22.03) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.5 (10.54 - 21.54) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.59 (10.50 - 22.08) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.39 (10.58 - 21.40) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.63 (10.85 - 21.78) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.62 (10.87 - 21.73) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.31 (10.70 - 21.44) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.45 (10.80 - 21.61) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.3 (10.59 - 22.02) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.64 (10.70 - 23.84) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.88 (10.71 - 24.95) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.16 (10.72 - 26.33) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.8 (10.06 - 25.66) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.15 (10.59 - 26.54) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.01 (10.27 - 26.53) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.45 (10.05 - 24.50) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.78 (10.05 - 22.37) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.16 (9.87 - 20.57) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.76 (9.78 - 19.28) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.41 (9.54 - 18.47) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.81 (9.29 - 17.29) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.52 (9.04 - 16.73) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.11 (9.45 - 17.61) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.2 (8.92 - 16.25) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.94 (8.81 - 16.02) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.73 (8.63 - 15.70) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.41 (8.38 - 15.32) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.93 (7.94 - 14.56) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,539 | 2016 | Modelled | WHO |
| 958 (647 - 1,358) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 964 (657 - 1,374) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,033 (695 - 1,454) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 998 (672 - 1,413) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,056 (718 - 1,467) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,082 (744 - 1,504) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,135 (787 - 1,581) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,171 (814 - 1,629) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,196 (836 - 1,673) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,225 (856 - 1,715) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,265 (876 - 1,821) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,338 (915 - 2,039) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,406 (948 - 2,209) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,532 (1,005 - 2,517) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,481 (982 - 2,412) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,609 (1,024 - 2,613) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,574 (1,009 - 2,608) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,631 (1,061 - 2,586) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,618 (1,100 - 2,449) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,607 (1,121 - 2,334) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,638 (1,165 - 2,255) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,620 (1,151 - 2,270) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,683 (1,220 - 2,272) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,661 (1,196 - 2,231) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,706 (1,232 - 2,281) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,725 (1,261 - 2,298) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,753 (1,293 - 2,350) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,786 (1,313 - 2,391) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,803 (1,325 - 2,421) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,793 (1,303 - 2,388) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,793 (1,303 - 2,388) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 50 | 2019 | Survey/reported | WHO/UNICEF |
| 52 | 2020 | Survey/reported | WHO/UNICEF |
| 58 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.1 (0.80 - 1.30) | 2015 | Modelled | Blach et al, 2017 |
| 3.5 (2.79 - 4.43) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.46 (2.75 - 4.36) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.43 (2.71 - 4.34) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.39 (2.71 - 4.27) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.36 (2.65 - 4.26) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.35 (2.66 - 4.22) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.34 (2.66 - 4.20) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.34 (2.67 - 4.20) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.34 (2.66 - 4.20) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.34 (2.66 - 4.20) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.33 (2.66 - 4.19) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.33 (2.66 - 4.17) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.33 (2.66 - 4.18) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.33 (2.66 - 4.18) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.32 (2.64 - 4.17) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.3 (2.65 - 4.13) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.26 (2.62 - 4.09) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.23 (2.59 - 4.05) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.2 (2.58 - 4.02) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.19 (2.56 - 4.01) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.2 (2.57 - 4.01) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.21 (2.59 - 4.02) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.23 (2.60 - 4.04) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.25 (2.59 - 4.06) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.26 (2.61 - 4.07) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.28 (2.63 - 4.08) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.29 (2.65 - 4.07) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.3 (2.66 - 4.09) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.31 (2.67 - 4.10) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.32 (2.68 - 4.11) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.37 (2.69 - 4.26) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.92 (0.63 - 1.05) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 162,000 (111,000 - 184,000) | 2015 | Modelled | Blach et al, 2017 |
| 196,862 (158,627 - 243,475) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 202,232 (163,143 - 250,765) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 207,755 (167,788 - 257,439) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 213,447 (171,581 - 264,891) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 219,387 (175,734 - 273,083) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 225,446 (180,011 - 281,191) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 231,575 (184,741 - 289,874) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 237,647 (191,074 - 297,621) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 243,930 (196,413 - 305,201) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 250,793 (201,603 - 314,920) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 258,451 (207,864 - 325,545) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 268,010 (215,861 - 337,809) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 279,674 (225,111 - 351,936) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 292,673 (235,438 - 367,080) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 306,216 (246,117 - 384,149) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 319,242 (254,104 - 401,910) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 331,691 (265,235 - 416,971) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 344,206 (275,064 - 431,868) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 357,033 (285,459 - 447,930) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 370,447 (295,219 - 465,755) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 384,643 (305,767 - 483,621) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 399,235 (318,259 - 502,651) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 413,767 (330,819 - 520,147) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 428,765 (340,534 - 538,437) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 444,887 (354,319 - 561,820) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 462,775 (365,300 - 585,741) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 484,583 (385,840 - 610,156) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 507,848 (401,381 - 644,067) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 531,411 (423,234 - 671,055) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 552,266 (441,035 - 697,983) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 556,873 (445,165 - 703,203) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 33,200 (22,800 - 37,700) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 1.47 (1 - 2.04) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 2.14 (1.45 - 2.96) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.08 (1.42 - 2.87) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.07 (1.42 - 2.89) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.07 (1.41 - 2.85) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.03 (1.41 - 2.83) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.01 (1.41 - 2.80) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.03 (1.41 - 2.81) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.02 (1.42 - 2.78) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.99 (1.40 - 2.75) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.97 (1.39 - 2.71) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.94 (1.37 - 2.71) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.92 (1.31 - 2.73) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.93 (1.34 - 2.69) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.92 (1.30 - 2.74) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.89 (1.28 - 2.72) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.82 (1.24 - 2.65) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.85 (1.26 - 2.66) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.81 (1.22 - 2.60) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.77 (1.21 - 2.51) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.74 (1.19 - 2.42) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.71 (1.17 - 2.39) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.68 (1.16 - 2.34) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.63 (1.13 - 2.27) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.5 (1.03 - 2.07) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.54 (1.05 - 2.15) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.59 (1.08 - 2.21) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.48 (1.03 - 2.04) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.47 (1.02 - 2.05) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.46 (1.01 - 2.05) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.47 (1 - 2.04) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 445 | 2016 | Modelled | WHO |
| 241 (164 - 335) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 241 (164 - 335) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 231 (160 - 324) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 224 (156 - 312) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 217 (151 - 299) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 212 (146 - 292) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 210 (143 - 293) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 208 (142 - 291) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 207 (143 - 287) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 205 (141 - 285) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 202 (138 - 282) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 197 (136 - 274) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 194 (133 - 274) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 191 (129 - 274) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 186 (126 - 270) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 182 (124 - 262) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 179 (121 - 258) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 176 (119 - 251) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 170 (116 - 242) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 165 (115 - 230) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 160 (113 - 224) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 157 (111 - 217) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 154 (109 - 213) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 151 (107 - 208) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 147 (103 - 204) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 141 (99 - 197) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 139 (96 - 193) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 136 (93 - 190) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 132 (90 - 182) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 129 (88 - 178) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 129 (87 - 178) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,793
2019
(1,303 - 2,388)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
241
2019
(164 - 335)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
10.79
(%)
2020, latest modelled
(9.15 - 12.78(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines